APNHF
Price
Loading...
Change
-$0.00 (-0.00%)
Updated
Loading...
Capitalization
2.53B
Intraday BUY SELL Signals
GEDSF
Price
Loading...
Change
-$0.00 (-0.00%)
Updated
Loading...
Capitalization
5.4B
Intraday BUY SELL Signals
Interact to see
Advertisement

APNHF vs GEDSF

Header iconAPNHF vs GEDSF Comparison
Open Charts APNHF vs GEDSFBanner chart's image
Aspen Pharmacare Holdings
PriceLoading...
Change-$0.00 (-0.00%)
Volume$101
Capitalization2.53B
Gedeon Richter
PriceLoading...
Change-$0.00 (-0.00%)
Volume$9.5K
Capitalization5.4B
APNHF vs GEDSF Comparison Chart in %
APNHF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
APNHF vs. GEDSF commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APNHF is a Hold and GEDSF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (APNHF: $6.23 vs. GEDSF: $22.29)
Brand notoriety: APNHF and GEDSF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: APNHF: 36% vs. GEDSF: 100%
Market capitalization -- APNHF: $2.53B vs. GEDSF: $5.4B
APNHF [@Pharmaceuticals: Generic] is valued at $2.53B. GEDSF’s [@Pharmaceuticals: Generic] market capitalization is $5.4B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APNHF’s FA Score shows that 1 FA rating(s) are green whileGEDSF’s FA Score has 1 green FA rating(s).

  • APNHF’s FA Score: 1 green, 4 red.
  • GEDSF’s FA Score: 1 green, 4 red.
According to our system of comparison, GEDSF is a better buy in the long-term than APNHF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APNHF’s TA Score shows that 2 TA indicator(s) are bullish.

  • APNHF’s TA Score: 2 bullish, 3 bearish.

Price Growth

APNHF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while GEDSF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.08%. For the same industry, the average monthly price growth was -3.24%, and the average quarterly price growth was +32.16%.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GEDSF($5.4B) has a higher market cap than APNHF($2.53B). APNHF has higher P/E ratio than GEDSF: APNHF (12.68) vs GEDSF (10.64). GEDSF YTD gains are higher at: -4.699 vs. APNHF (-49.122). GEDSF has higher annual earnings (EBITDA): 335B vs. APNHF (2.16B). GEDSF has more cash in the bank: 150B vs. APNHF (6.41B). GEDSF has less debt than APNHF: GEDSF (21.6B) vs APNHF (36.1B). GEDSF has higher revenues than APNHF: GEDSF (903B) vs APNHF (43.4B).
APNHFGEDSFAPNHF / GEDSF
Capitalization2.53B5.4B47%
EBITDA2.16B335B1%
Gain YTD-49.122-4.6991,045%
P/E Ratio12.6810.64119%
Revenue43.4B903B5%
Total Cash6.41B150B4%
Total Debt36.1B21.6B167%
FUNDAMENTALS RATINGS
APNHF vs GEDSF: Fundamental Ratings
APNHF
GEDSF
OUTLOOK RATING
1..100
2950
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
2
Undervalued
PROFIT vs RISK RATING
1..100
10065
SMR RATING
1..100
9948
PRICE GROWTH RATING
1..100
8871
P/E GROWTH RATING
1..100
8781
SEASONALITY SCORE
1..100
5030

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GEDSF's Valuation (2) in the null industry is in the same range as APNHF (19). This means that GEDSF’s stock grew similarly to APNHF’s over the last 12 months.

GEDSF's Profit vs Risk Rating (65) in the null industry is somewhat better than the same rating for APNHF (100). This means that GEDSF’s stock grew somewhat faster than APNHF’s over the last 12 months.

GEDSF's SMR Rating (48) in the null industry is somewhat better than the same rating for APNHF (99). This means that GEDSF’s stock grew somewhat faster than APNHF’s over the last 12 months.

GEDSF's Price Growth Rating (71) in the null industry is in the same range as APNHF (88). This means that GEDSF’s stock grew similarly to APNHF’s over the last 12 months.

GEDSF's P/E Growth Rating (81) in the null industry is in the same range as APNHF (87). This means that GEDSF’s stock grew similarly to APNHF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APNHFGEDSF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
N/A
Momentum
ODDS (%)
Bullish Trend 2 days ago
27%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
15%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
20%
Bullish Trend 2 days ago
29%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
11%
Bullish Trend 2 days ago
25%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
44%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
APNHF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JOPSX14.690.13
+0.89%
JOHCM International Opps Institutional
ANWPX75.290.24
+0.32%
American Funds New Perspective A
VYMVX19.150.02
+0.10%
Voya MI Dynamic SMID Cap R
CFIMX15.530.01
+0.06%
Clipper
FIKNX20.30N/A
N/A
Fidelity Advisor Small Cap Value Z

APNHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, APNHF has been loosely correlated with GEDSF. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if APNHF jumps, then GEDSF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APNHF
1D Price
Change %
APNHF100%
N/A
GEDSF - APNHF
51%
Loosely correlated
N/A
ORXOY - APNHF
29%
Poorly correlated
N/A
QNTM - APNHF
4%
Poorly correlated
-3.31%
ORGO - APNHF
1%
Poorly correlated
-0.31%
YCBD - APNHF
1%
Poorly correlated
-3.72%
More

GEDSF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GEDSF has been loosely correlated with APNHF. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if GEDSF jumps, then APNHF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GEDSF
1D Price
Change %
GEDSF100%
N/A
APNHF - GEDSF
51%
Loosely correlated
N/A
UPC - GEDSF
4%
Poorly correlated
+2.22%
KKPCF - GEDSF
3%
Poorly correlated
N/A
CLCFF - GEDSF
3%
Poorly correlated
+33.71%
OPTHF - GEDSF
0%
Poorly correlated
N/A
More